Does plasmin have anticoagulant activity?

References

• LoweGDCommon risk factors for both arterial and venous thrombosisBr J Haematol200814048849518275426
   PubMed Web of Science ®Google Scholar
• PlowEFHerrenTRedlitzAMilesLAHoover-PlowJLThe cell biology of the plasminogen systemFASEB J199599399457615163
   PubMed Web of Science ®Google Scholar
• CarmelietPCollenDDevelopment and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation systemThromb Res1998912552859772009
   PubMed Web of Science ®Google Scholar
• OguraYMatsunagaYNishiyamaTAmanoSPlasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junctionBr J Dermatol2008159496018460030
   PubMed Web of Science ®Google Scholar
• MoserTLEnghildJJPizzoSVStackMSThe extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activatorJ Biol Chem199326818917189238360181
   PubMed Web of Science ®Google Scholar
• LiottaLAGoldfarbRHBrundageGPEffect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membraneCancer Res198141462946366458354
   PubMed Web of Science ®Google Scholar
• LijnenHRPlasmin and matrix metalloproteinases in vascular remodelingThromb Haemost20018632433311487021
   PubMed Web of Science ®Google Scholar
• GongYHartEShchurinAHoover-PlowJInflammatory macrophage migration requires MMP-9 activation by plasminogen in miceJ Clin Invest20081183012302418677407
   PubMed Web of Science ®Google Scholar
• ColemanCTuanTLBuckleySAndersonKDWarburtonDContractility, transforming growth factor-beta, and plasmin in fetal skin fibroblasts: Role in scarless wound healingPediatr Res1998434034099505281
   PubMed Web of Science ®Google Scholar
• ShanmukhappaKMatteUDegenJLBezerraJAPlasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repairJ Biol Chem2009284129171292319286661
   PubMed Web of Science ®Google Scholar
• WangNZhangLMilesLHoover-PlowJPlasminogen regulates pro-opiomelanocortin processingJ Thromb Haemost2004278579615099286
   PubMed Web of Science ®Google Scholar
• JiangQJTaupenotLMahataSKProteolytic cleavage of chromogranin A (CgA) by plasmin – selective liberation of a specific bioactive CgA fragment that regulates catecholamine releaseJ Biol Chem2001276250222502911342539
   PubMed Web of Science ®Google Scholar
• OmarMNMannKGInactivation of factor Va by plasminJ Biol Chem1987262975097552954962
   PubMed Web of Science ®Google Scholar
• PasquiniRHershgoldEJEffects of plasmin on human factor VIII (AHF)Blood1973411051114118107
   PubMed Web of Science ®Google Scholar
• SamisJARamseyGDWalkerJBNesheimMEGilesARProteolytic processing of human coagulation factor IX by plasminBlood20009594395110648407
   PubMed Web of Science ®Google Scholar
• PryzdialELKesslerGEAutoproteolysis or plasmin-mediated cleavage of factor Xaalpha exposes a plasminogen binding site and inhibits coagulationJ Biol Chem199627116614166208663221
   PubMed Web of Science ®Google Scholar
• LiAWunTCProteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: Effect on TFPI activityThromb Haemost1998804234279759622
   PubMed Web of Science ®Google Scholar
• CollenDThe plasminogen (fibrinolytic) systemThromb Haemost19998225927010605712
   PubMed Web of Science ®Google Scholar
• HaywardCPFurmaniak-KazmierczakECieutatAMFactor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granulesJ Biol Chem199527019217192247642592
   PubMed Web of Science ®Google Scholar
• LeeCDMannKGActivation/inactivation of human factor V by plasminBlood1989731851902521293
   PubMed Web of Science ®Google Scholar
• KalafatisMMannKGThe role of the membrane in the inactivation of factor Va by plasmin. Amino acid region 307–348 of factor V plays a critical role in factor Va cofactor functionJ Biol Chem2001276186141862311278331
   PubMed Web of Science ®Google Scholar
• ZeibdawiARPryzdialELMechanism of factor Va inactivation by plasmin. Loss of A2 and A3 domains from a Ca2+-dependent complex of fragments bound to phospholipidJ Biol Chem2001276199291993611278280
   PubMed Web of Science ®Google Scholar
• RosendorffADorfmanDMActivated protein C resistance and factor V Leiden: A reviewArch Pathol Lab Med200713186687117550313
   PubMed Web of Science ®Google Scholar
• CuiJO’SheaKSPurkayasthaASaundersTLGinsburgDFatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor VNature199638466688900278
   PubMed Web of Science ®Google Scholar
• CuiJEitzmanDTWestrickRJSpontaneous thrombosis in mice carrying the factor V Leiden mutationBlood2000964222422611110695
   PubMed Web of Science ®Google Scholar
• DonatiMBdeGGVermylenJVerstraeteMInhibition of human platelet aggregation by plasmin digests of human factor VIIIBlood1973427497514270477
   PubMed Web of Science ®Google Scholar
• RickMEKrizekDMPlatelets modulate the proteolysis of factor VIII: C protein by plasminBlood198667164916542939896
   PubMed Web of Science ®Google Scholar
• NogamiKFreasJManithodyCMechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domainJ Biol Chem2004279331043311315166225
   PubMed Web of Science ®Google Scholar
• NogamiKNishiyaKSaenkoELIdentification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chainBiochim Biophys Acta2008178475376318329389
   PubMed Web of Science ®Google Scholar
• BiLLawlerAMAntonarakisSETargeted disruption of the mouse factor VIII gene produces a model of haemophilia ANat Genet1995101191217647782
   PubMed Web of Science ®Google Scholar
• MonahanPEFactor IX: Insights from knock-out and genetically engineered miceThromb Haemost200810056357518841277
   PubMed Web of Science ®Google Scholar
• PryzdialELGLavigneNDupuisNKesslerGEPlasmin converts factor X from coagulation zymogen to fibrinolysis cofactorJ Biol Chem19992748500850510085082
   PubMed Web of Science ®Google Scholar
• GrundyJELavigneNHiramaTMacKenzieCRPryzdialELGBinding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor XaBiochemistry2001406293630211371191
   PubMed Web of Science ®Google Scholar
• GrundyJEHancockMAMeixnerSCPlasminogen binds to plasmin-modulated factor Xa by Ca(2+) – and C-terminal lysine-dependent and -independent interactionsThromb Haemost200797384417200769
   PubMed Web of Science ®Google Scholar
• DewerchinMLiangZMoonsLBlood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in miceThromb Haemost20008318519010739370
   PubMed Web of Science ®Google Scholar
• TaiSJHerzogRWMargaritisPA viable mouse model of factor X deficiency provides evidence for maternal transfer of factor XJ Thromb Haemost2008633934518036190
   PubMed Web of Science ®Google Scholar
• LiYSpencerFABeckerRCPlasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorJ Thromb Thrombolysis200315192314574072
   PubMed Web of Science ®Google Scholar
• HuangZFHiguchiDLaskyNBrozeGJJrTissue factor pathway inhibitor gene disruption produces intrauterine lethality in miceBlood1997909449519242522
   PubMed Web of Science ®Google Scholar
• MatsunoHKozawaOOkadaKPlasmin generation plays different roles in the formation and removal of arterial and venous thrombus in miceThromb Haemost2002879810411848464
   PubMed Web of Science ®Google Scholar
• KawasakiTDewerchinMLijnenHRVermylenJHoylaertsMFVascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in miceBlood20009615316010891445
   PubMed Web of Science ®Google Scholar
• EitzmanDTWestrickRJNabelEGGinsburgDPlasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in miceBlood20009557758010627465
   PubMed Web of Science ®Google Scholar
• MatsunoHKozawaONiwaMDifferential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injuryThromb Haemost19998160160410235447
   PubMed Web of Science ®Google Scholar
• Hoover-PlowJHartESaranitiJApo(a) increases clot stability in transgenic miceJ Thromb Haemost20097Suppl 2Abstract PP-WE-239.
   Google Scholar
• FarrehiPMOzakiCKCarmelietPFayWPRegulation of arterial thrombolysis by plasminogen activator inhibitor-1 in miceCirculation199897100210089529269
   PubMed Web of Science ®Google Scholar
• KonstantinidesSSchäferKThinnesTLoskutoffDJPlasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in miceCirculation200110357658311157725
   PubMed Web of Science ®Google Scholar
• ZhuYCarmelietPFayWPPlasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistanceCirculation1999993050305510368124
   PubMed Web of Science ®Google Scholar
• WangXChengQXuLEffects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in miceJ Thromb Haemost2005369570215733058
   PubMed Web of Science ®Google Scholar
• Hoover-PlowJShchurinAHartEGenetic background determines response to hemostasis and thrombosisBMC Blood Disord20066617022820
   PubMedGoogle Scholar
• MackmanNTissue-specific hemostasis in miceArterioscler Thromb Vasc Biol2005252273228116123318
   PubMed Web of Science ®Google Scholar
• StalboergerPGPanettaCJSimariRDCapliceNMPlasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitorThromb Haemost20018692392811583328
   PubMed Web of Science ®Google Scholar
• TangHIvanciuLPopescuNSepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitorAm J Pathol20071711066107717640967
   PubMed Web of Science ®Google Scholar
• ChengQZhaoYLawsonWEThe effects of intrinsic pathway protease deficiencies on plasminogen-deficient miceBlood20051063055305715985536
   PubMed Web of Science ®Google Scholar
• EllisKBrenerSNew fibrinolytic agents for MI: As effective as current agents, but easier to administerCleve Clin J Med200471202714740966
   PubMed Web of Science ®Google Scholar
• BottigerBWArntzHRChamberlainDAThrombolysis during resuscitation for out-of-hospital cardiac arrestN Engl J Med20083592651266219092151
   PubMed Web of Science ®Google Scholar
• GautierSPetraultOGelePInvolvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial functionStroke2003342975297914615621
   PubMed Web of Science ®Google Scholar
• ThomasGRThibodeauxHErrettCJA long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleedingStroke199425207220788091454
   PubMed Web of Science ®Google Scholar
• SuzukiYNagaiNCollenDComparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in miceJ Thromb Haemost200421617162115333039
   PubMed Web of Science ®Google Scholar
• SazonovaIYThomasBMGladyshevaIPHoungAKReedGLFibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrateJ Thromb Haemost200752087209417883703
   PubMed Web of Science ®Google Scholar
• WuQZhaoZInhibition of PAI-1: A new anti-thrombotic approachCurr Drug Targets Cardiovasc Haematol Disord20022274212769655
   PubMedGoogle Scholar
• WestrickRJEitzmanDTPlasminogen activator inhibitor-1 in vascular thrombosisCurr Drug Targets20078966100217896948
   PubMed Web of Science ®Google Scholar
• MarderVJThrombolytic therapy for deep vein thrombosis: Potential application of plasminThromb Res2009123S566119303506
   PubMed Web of Science ®Google Scholar
• NagaiNDemarsinEVan HoefBWoutersSCingolaniDRecombinant human microplasmin: Production and potential therapeutic propertiesJ Thromb Haemost2003130731312871505
   PubMed Web of Science ®Google Scholar
• LapchakPAAraujoDMPakolaSMicroplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbitsStroke2002332279228412215599
   PubMed Web of Science ®Google Scholar
• Diaz-LlopisMUdaondoPArevaloFIntravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edemaJ Ocul Pharmacol Ther20092537938419650710
   PubMed Web of Science ®Google Scholar
• GandorferAMicroplasmin-assisted vitrectomyDev Ophthalmol200944263019494649
   PubMedGoogle Scholar
• WattsPSureshPMezerEEffective treatment of ligneous conjunctivitis with topical plasminogenAm J Ophthalmol200213345145511931777
   PubMed Web of Science ®Google Scholar
• ComerotaAJDevelopment of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusionThromb Res2008122S202618701142
   PubMed Web of Science ®Google Scholar